Victor Grann, M.D., F.A.C.P.; Stuart Finch, M.D.; Bayard Clarkson, M.D., F.A.C.P.; Robert Erichson, M.D., F.A.C.P.; Arthur Rosenberg, M.D., F.A.C.P.
This content is PDF only. Please click on the PDF icon to access.
Patients older than 50 years, with acute granulocytic leukemia are widely considered to be resistant to current chemotherapy. The records of 96 patients, 50 to 91 years of age, treated from 1967 to 1972 at Memorial Sloan-Kettering Cancer Center, Yale-New Haven Medical Center, and eight community hospitals in Connecticut, were reviewed. No difference was detected in patients' response among the participating hospitals. Thirty-four percent of the 96 patients experienced a complete remission. Of those considered adequate for evaluation (survival longer than 1 month), 33 of 77 patients (41%) experienced a complete remission. The proportion of patients responding to therapy did
Grann V, Finch S, Clarkson B, Erichson R, Rosenberg A. Acute Granulocytic Leukemia in Patients Over 50.. Ann Intern Med. ;78:824. doi: 10.7326/0003-4819-78-5-824_3
Download citation file:
Published: Ann Intern Med. 1973;78(5):824.
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use